Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStaying well-hydrated on Wegovy matters more than most people expect. Semaglutide slows gastric emptying and commonly causes nausea, vomiting and diarrhoea, all of which make fluid loss a real concern, particularly in the first weeks of treatment. Getting your water intake right won't speed up weight loss on its own, but it can make the medicine significantly more comfortable to take. These are prescription-only medicines, and the specifics of how much fluid you personally need are best confirmed by a prescriber who knows your health picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing the rate at which food leaves your stomach. That's useful for appetite, but it also means nausea, burping and a feeling of uncomfortable fullness are common, especially after dose increases. Many people find they lose the habit of drinking regularly because the sensation of a full stomach discourages it.
At the same time, if vomiting or diarrhoea occur in those first few weeks, you're losing fluid faster than normal. The combination of drinking less and losing more is what tips people into dehydration. The NHS medicines page for semaglutide lists dehydration, and the kidney problems it can cause, among the side effects that need prompt attention, so this isn't a minor concern to file away for later.
If you're curious about how water balance shifts specifically during weight loss on semaglutide, the detail on how Wegovy affects water weight fills in a useful part of the picture.
General UK guidance suggests around 6 to 8 cups (roughly 1.5 to 2 litres) of fluid per day for most adults, but that figure assumes normal eating and no unusual losses. On Wegovy, particularly when GI side effects are active, you may need more than that baseline, not less.
The approach most people find workable is keeping a small glass nearby and sipping consistently, rather than trying to down a pint before a meal. Large volumes of liquid at once can worsen the sensation of fullness and trigger nausea. Think of it the way you might think of breakfast: the tablet version of semaglutide asks you to take it first thing on an empty stomach before the kettle even goes on, and the same steady-before-rushing logic applies to fluids throughout the day.
Plain water is the baseline. Herbal teas and diluted no-added-sugar squash count. Alcohol is worth limiting because it compounds dehydration and adds calories that work against what the medicine is trying to help you achieve. Caffeine in moderate amounts is fine; just don't rely on coffee to hit your fluid total.
If you want a broader grounding in how semaglutide works and what lifestyle changes support it, the overview on semaglutide for weight management covers the essentials.
Mild nausea with reduced thirst is common and usually settles as your body adjusts to each new dose. What needs attention is a different picture: not passing urine for many hours, dark urine, dizziness on standing, a dry mouth you can't shift, or vomiting so frequent that you can't keep fluids down at all.
Those are signs that dehydration may be affecting your kidneys. The right response is to contact your GP or NHS 111, not to simply drink more and hope. If you are on Wegovy through a regulated service, your aftercare team is also there for exactly this. At nume, prescriber-led aftercare runs seven days a week, so you're never left guessing between doses.
Separately, Wegovy is not appropriate for people with significant gastric-emptying problems. If you have a history of gastroparesis or similar conditions, the page on Wegovy and gastroparesis sets out what the clinical guidance says. A prescriber makes the suitability call; that's not something self-assessment alone can resolve.
A separate question comes up regularly: some people notice the opposite of dehydration in the early weeks, puffiness or a sense of fluid retention, particularly as they adjust doses or change eating patterns. This is distinct from hydration and relates more to how the body redistributes sodium and fluids as diet changes. If that's the concern rather than dehydration, the guide to Wegovy and water retention explains the mechanisms and what tends to resolve on its own versus what's worth raising with a clinician.
The broader Wegovy and water topic covers both ends of this, with links to each specific concern. And for anyone still weighing up whether Wegovy is the right treatment for them, the Wegovy overview gives a grounded account of the medicine's evidence base and how private prescribing works.
Wegovy is a prescription-only medicine. The free consultation at nume is the starting point: a GPhC-registered prescriber reviews your answers the same day and confirms whether treatment is clinically appropriate for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.